Cargando…
Galectin-2 in Health and Diseases
Galectin-2 is a prototype member of the galactoside-binding galectin family. It is predominately expressed in the gastrointestinal tract but is also detected in several other tissues such as the placenta and in the cardiovascular system. Galectin-2 expression and secretion by epithelial cells has be...
Autores principales: | Negedu, Muhammed N., Duckworth, Carrie A., Yu, Lu-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820181/ https://www.ncbi.nlm.nih.gov/pubmed/36613785 http://dx.doi.org/10.3390/ijms24010341 |
Ejemplares similares
-
Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
por: Duckworth, Carrie A., et al.
Publicado: (2015) -
C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression
por: Wan, Yangu, et al.
Publicado: (2023) -
The universe of galectin-binding partners and their functions in health and disease
por: Troncoso, María F., et al.
Publicado: (2023) -
Serum galectins as potential biomarkers of inflammatory bowel diseases
por: Yu, Tony B., et al.
Publicado: (2020) -
Galectin-3 in Cardiovascular Diseases
por: Blanda, Valeria, et al.
Publicado: (2020)